BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1521470)

  • 1. Immunity and immune privilege elicited by autoantigens expressed on syngeneic neonatal neural retina grafts.
    Jiang LQ; Streilein JW
    Curr Eye Res; 1992 Jul; 11(7):697-709. PubMed ID: 1521470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
    Jiang LQ; Streilein JW
    Reg Immunol; 1990-1991; 3(3):121-30. PubMed ID: 2098067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts.
    Jiang LQ; Jorquera M; Streilein JW
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3347-54. PubMed ID: 8225870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses elicited by transplantation and tissue-restricted antigens expressed on retinal tissues implanted subconjunctivally.
    Jiang LQ; Streilein JW
    Transplantation; 1991 Sep; 52(3):513-9. PubMed ID: 1897026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconventional rejection of neural retinal allografts implanted into the immunologically privileged site of the eye.
    Jiang LQ; Jorquera M; Streilein JW; Ishioka M
    Transplantation; 1995 Apr; 59(8):1201-7. PubMed ID: 7732567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that retinal pigment epithelium functions as an immune-privileged tissue.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3467-73. PubMed ID: 11006240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants.
    Grisanti S; Ishioka M; Kosiewicz M; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1619-26. PubMed ID: 9224290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immune deviation elicited by antigens injected into the subretinal space.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic neonatal neuronal retina grafts display partial immune privilege in the subcapsular space of the kidney.
    Ng TF; Osawa H; Hori J; Young MJ; Streilein JW
    J Immunol; 2002 Nov; 169(10):5601-6. PubMed ID: 12421938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts.
    Jiang LQ; Jorquera M; Streilein JW
    Exp Eye Res; 1994 Jun; 58(6):719-28. PubMed ID: 7925711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology and privilege of neuronal retina and pigment epithelium transplants.
    Streilein JW; Ma N; Wenkel H; Ng TF; Zamiri P
    Vision Res; 2002 Feb; 42(4):487-95. PubMed ID: 11853765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts.
    Ma N; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2384-93. PubMed ID: 9804147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
    Wang M; Yoshida A; Kawashima H; Ishizaki M; Takahashi H; Hori J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1522-32. PubMed ID: 16565388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune privilege extended to allogeneic tumor cells in the vitreous cavity.
    Jiang LQ; Streilein JW
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):224-8. PubMed ID: 1987103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of survival of intraocular neural retinal grafts by prior antigen-specific immune deviation.
    Jiang LQ; Streilein JW
    Transplant Proc; 1992 Dec; 24(6):2883-4. PubMed ID: 1465983
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.